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A commentary on
Impact of a deletion of the full-length and short isoform of p75NTR on cholinergic innervation
and the population of postmitotic doublecortin positive cells in the dentate gyrus
by Poser, R., Dokter, M., von Bohlen und Halbach, V., Berger, S. M., Busch, R., Baldus, M., et al.
(2015). Front. Neuroanat. 9:63. doi: 10.3389/fnana.2015.00063
We read with great interest the article by Poser et al. (2015). Full-length human/murine P75NTR
(FL-p75NTR; ENST00000172229, ENSMUST00000000122, ENSRNOT00000007268) is encoded
by six exons. Four cysteine-rich repeats span P75NTR extracellular domain and exhibit high-pro-
neurotrophins-affinity and low-affinity to mature neurotrophins.
Brain P75NTR plays pivotal roles in neurogenesis. Embryonic neurogenesis derives from
ventricular zone radial glia (Mochida et al., 2007). Adult neurogenesis is localized to stem cell
niches in hippocampal dentate gyrus and the sub-ventricular zone (SVZ). P75NTR is detected
in deep layers of developing neocortex (Bishop et al., 2002) and defines adult neurogenesis stem
cells in SVZ (Young et al., 2007) and hippocampus (Catts et al., 2008). P75NTR regulates synaptic
plasticity through its interactions with pro-BNDF to produce long-term depression (Woo and Lu,
2009). P75NTR Interacts with Nogo/Lingo-1 leading to growth cone collapse, neurite retraction,
and spine density decrease (Meeker and Williams, 2015).
An alternative 62 kD P75NTR variant, named short isoform (s-p75NTR), claimed to arise
by alternative splicing of P75NTR exon III, has been reported in the mouse and was claimed
to also exist in rat and human species (von-Schack et al., 2001; Naumann et al., 2002). Exon
III encodes cysteine-motifs 2–4 (Casaccia-Bonnefil et al., 1999). Its deletion would compromise
P75NTR interaction with several molecules including Nogo (see above), sortilin and Trk. P75NTR-
sortilin binding increases pro-neurotrophin affinity and promotes apoptosis while P75NTR-Trk
interaction mediates pro-survival functions (Meeker and Williams, 2015).
To verify the existence of the presumed mouse s-p75NTR, we conducted Rapid Amplification
of cDNA Ends (RACE) cloning on mouse P75NTR mRNA and ascertained many exon
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FIGURE 1 | Verifying P75NTR isoforms. (I) RACE cloning to explore potential additional P75NTR variants: RACE cloning was conducted using a 225 bp template
representing mouse brain P75NTR exon 4 nucleotides 781–1005. A large number of clones were screened, sequenced and BLASTed against mouse Refseq
database (NCBI). Several exon III-containing clones (red lines in the shaded area) were ascertained while none of the screened clones showed exon III-skipping of the
claimed s-p75NTR. (II) Exploring mouse brain cDNA for the presence of s-p75NTR: RT-PCR amplification was conducted using exon III-flanking primer pair
5′CCTGCCTGGACAGTGTTACG-3′/5′-GCCAAGATGGAGCAATAGACAG-3′ in lane (1) for FL-p75NTR amplification & exon III-skipping primer pairs
5′-TGCCTGGACAAGATCCCTGG-3′/5′-GGCCTGAGGCAGTCTGTGTG-3′ in panel (2) for possible amplification of the claimed s-p75NTR. RT-PCR was followed by
electrophoresis on 2% agarose gel. In lane 1, a 550 bp band was amplified which, on sequenced, was found to represent FL-p75NTR (contains exon III). No
amplification was detected for the claimed s-p75NTR in lane 2. L = 100 bp ladder, 1 and 2 = Adult mouse brain cDNA. (III) Exploring murine/human P75NTR protein
variants. SDS-PAGE followed by WB of adult brain protein extracts from mouse (lane A-1), rat (lane A-2), human control (lane B-1), Alzheimer’s disease (lanes B-2a,
B2b, and C-2c), and CLL cell line K562 (lane C-3) using rabbit polyclonal antibody ANT-011 (Almone Labs) reactive to peptide CKQNKQGANSRPVNQT
corresponding to residues 278–293 of human P75NTR (SwissProt accession P08138) with cross-reactivity to mouse and rat P75NTR. Only one band (75 kD),
corresponding to FL-p75NTR is detected in protein extracts from mouse and rat. No 62 kD band (of the claimed s-p75NTR) was detected in either mouse, rat, adult
human brain or human CLL cell line K562. Two protein bands (75 and 36 kD) are identified in protein extracts from human brain control/Alzheimer’s disease
corresponding to FL-p75NTR and the newly identified 36 kD human P75NTR variant.
III-containing clones without any evidence of continuous exon
II/exon IV sequence with exon III-skipping (Figure 1I). Also
we conducted RT-PCR using oligos flanking exon III and
validated our results by sequencing the identified PCR fragments
(Figure 1II). Additionally, we used the same discontinuous, exon
III-skipping primers which were used in the original reports as
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“specific” oligos to the presumed s-75NTR variant (von-Schack
et al., 2001). These specific primers contain exons 2/4 boundary
sequences. Also, this approach did not identify any short, exon
III-excluding isoform in the mouse (Figure 1II).
Western blotting (WB) on mouse, rat, and human brain
protein extracts using polyclonal antibodies specific to the
intracellular region of P75NTR (Figure 1III) identified the 75
kD FL-p75NTR in the three species while a 62 kD band
(corresponding to the claimed s-p75NTR) was not detected
in any of the three species investigated. Apart from 75 kD
FL-p75NTR, no other bands were detected in mouse and rat
brains (Figure 1III). Of note is the fact that the report by
(von-Schack et al., 2001) failed to show the protein band
corresponding to the presumed 62 kD s-p75NTR in their WB.
They rather showed a WB “smear” around 75 kD and argued
that the 62 kD s-p75NTR band has been masked by the high
level expression of FL-p75NTR! This is hardly convincing since
the issue could have been easily resolved by simple technical
improvements. It is noteworthy that our results, verifying
only one murine FL-p75NTR band, are compatible with the
documentations in major resources like Ensembl, NCBI, and
UniProt database.
In addition to the 75 kD FL-p75NTR, our WB results on
control and Alzheimer’s disease human brains also detected
an additional, previously unreported, human 36 kD isoform,
(Figure 1III). The 36 kD P75NTR isoform does not seem to
be a marker for Alzheimer’s disease since we detected the two
isoforms (75 and 36 kD), either simultaneously or alternatively,
in individual human samples from control or Alzheimer’s brains
(Figure 1III). It is notable that three protein-coding P75NTR
human transcripts (ENST00000172229, ENST00000504201, and
ENST00000509200) are listed in ENSEMBL and UniProt. We are
embarking on further analysis to determine the nature of our 36
kD isoform.
It is seriously alarming that the report by von-Schack et al.
(2001) did not show any experimental work to support their
claim for the presence of a 62 kD s-p75NTR. In addition to the
lack of WB evidence, they did not even sequence their RT-PCR
fragments to prove their claims. Such unsubstantiated reporting
caused considerable confusion in the neuroscience community
since other groups (Fujii and Kunugi, 2009; Poser et al., 2015)
innocently reiterated such un-validated reports and, moreover,
interpreted their important results based on such unfounded
claims (Poser et al., 2015).
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